Test Bank - Rau’s Respiratory Care Pharmacology, 11th Edition (Gardenhire, 2024), Chapter 1-23 | All Chapters

,Description
Test Bank for Rau’s Respiratory Care Pharmacology 11th Edition Gardenhire
f f f f f f f f f




Test Bank for Rau’s Respiratory Care Pharmacology, 11th Edition, Gardenhire, ISBN-10:
f f f f f f f f f f


0323299687, ISBN-13: 9780323299688
f f f




Table of Contents f f




Unit I: Basic Concepts and Principles in Pharmacology
f f f f f f f




1. Introduction to Respiratory Care Pharmacology
f f f f f


2. Principles of Drug Action
f f f f


3. Administration of Aerosolized Agents
f f f f


4. Calculating Drug Doses
f f f


5. The Central and Peripheral Nervous Systems
f f f f f f




Unit II: Drugs Used to Treat the Respiratory System
f f f f f f f f




6. Adrenergic (Sympathomimetic) Bronchodilators
f f f


7. Anticholinergic (Parasympatholytic) Bronchodilators
f f f


8. Xanthines
f


9. Mucus-Controlling Drug Therapy
f f f


10. Surfactant Agents
f f


11. Corticosteriods in Respiratory Care
f f f f


12. Nonsteroidal Antiasthma Agents
f f f


13. Aerosolized Antiinfective Agents
f f f


14. Antimicrobial Agents
f f


15. Cold and Cough Agents
f f f f


16. Selected Agents of Pulmonary Value
f f f f f


17. Neonatal and Pediatric Aerosolized Drug Therapy
f f f f f f




Unit III: Critical Care, Cardiovascular, and Polysomnography Agents
f f f f f f f




18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
f f f f f f


19. Diuretic Agents
f f


20. Drugs Affecting the Central Nervous System
f f f f f f


21. Vasopressors, Inotropes, and Antiarrythmic Agents
f f f f f


22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
f f f f f f


23. Sleep and Sleep Pharmacology
f f f f

,Chapter 01: Introduction to Respiratory Care Pharmacology Gardenhire:
f f f f f f f




Rau’s Respiratory Care Pharmacology, 11th Edition
f f f f f f




MULTIPLE CHOICE f




1. What is the name of the receptor sites that are located in the peripheral vasculature, the heart, bronchial
f f f f f f f f f f f f f f f f f


muscle, and bronchial blood vessels?
f f f f f


a. Beta 2 receptors f f c. Alpha receptors f


b. Gamma receptors d. Beta 1 receptors
f f f f f




ANS: C f


Alpha receptors are located in the peripheral vasculature, the heart, bronchial muscle, and bronchial
f f f f f f f f f f f f f


blood vessels.
f f




PTS: 1 f




2. Which receptor site results in tachycardia, an increased potential for arrhythmias, and an increased
f f f f f f f f f f f f f


cardiac output?
f f


a. Beta 1 receptor f f c. Alpha receptor f


b. Beta 2 receptor f f d. Delta receptor f f




ANS: A f


Stimulation of the beta-1 receptors results in tachycardia, an increased potential for arrhythmias, and an
f f f f f f f f f f f f f f


increased cardiac output. In administering drugs to the pulmonary system, stimulation of the beta-1 sites
f f f f f f f f f f f f f f f


is not desired. However, most respiratory pharmacologic agents have some beta-1 stimulatory effect.
f f f f f f f f f f f f f




PTS: 1 f




3. Stimulation of the beta 2 receptors causes f f f f f f f


a. peripheral vasoconstriction and mild bronchoconstriction in the lungs.
f f f f f f f


b. tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
f f f f f f f f f f


c. bronchodilation.
d. peripheral vasodilation, bradycardia, and decreased cardiac output.
f f f f f f




ANS: C f


Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
f f f f f f f f f




PTS: 1 f




4. Acetylcholine stimulates f f


a. the Vagus nerve. f f


b. the adrenergic receptors. f f


c. the sympathetic nervous system.
f f f


d. the cholinergic receptors.f f




ANS: D f


Acetylcholine stimulates the cholinergic receptors. f f f f




PTS: 1 f




5. What immunoglobulin antibody sensitizes the mast cell?
f f f f f f


a. Leukotrienes c. Histamine

, b. IgE d. Prostaglandins
f




ANS: B f


The IgE (reagin) antibodies sensitize the mast cell. Repeated exposure to the antigen causes the
f f f f f f f f f f f f f f


degranulation of the mast cell.
f f f f f




PTS: 1 f




6. Which of the following is caused by histamine release from the mast cells?
f f f f f f f f f f f f


I. Bronchodilation
II. Increased bronchial gland secretion f f f


III. Increased amount of mucus present in the airways f f f f f f f


a. I and II onlyf f c. III onlyf f


b. II and III only f fd. I, II, III f f f f f




ANS: B f


Histamine is also a potent bronchoconstrictor. In addition to its bronchoconstrictive activity, histamine
f f f f f f f f f f f f



II) increases bronchial gland secretion, causing III) an increase in the amount of mucus present in
f f f f f f f f f f f f f f f


the airways. Histamine may also have an effect on vascular permeability similar to the effect of-
f f f f f f f f f f f f f f f f


SRS-A.
f




PTS: 1 f




7. A sympathomimetic drug would cause
f f f f f


a. bronchodilation. c. Histamine release. f


b. bronchoconstriction. d. Vagus nerve stimulation.
f f f




ANS: A f


A sympathomimetic drug would cause bronchodilation. Sympathomimetic agents are the drugs most commonly
f f f f f f f f f f f f



used to reverse bronchospasm.
f f f f




PTS: 1 f




8. Stimulation of the sympathetic nervous system causes f f f f f f f


a. vascular permeability. c. bronchodilation.
f


b. decreased blood pressure. d. bronchoconstriction. f f f




ANS: C f


Sympathetic nervous system stimulation causes bronchodilation. f f f f f




PTS: 1 f




9. Which of the following would NOT cause a bronchospasm or bronchoconstriction?
f f f f f f f f f f


a. Leukotrienes c. Histamine
b. Beta 1 receptors f d. Prostaglandins
f f




ANS: B f


Beta-1 receptors would not cause a bronchospasm or bronchoconstriction. Leukotrienes are one of
f f f f f f f f f f f f


many chemical mediators released by the mast cells. Leukotrienes cause a direct, strong
f f f f f f f f f f f f f


bronchoconstriction. Histamine is also a potent bronchoconstrictor. Prostaglandins cause a strong
f f f f f f f f f f f


bronchospasm, especially in asthmatic patients.
f f f f f




PTS: 1 f